Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
Authors:
- T DoiTDT Doi
- H EndoHEH Endo
- Y HosokawaYHY Hosokawa
- Y NishikawaYNY Nishikawa
- M TanimizuMTM Tanimizu
- K JinnoKJK Jinno
- Y KotaniYKY Kotani
- 1 December 1998
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 34 (13) , 2041-2045
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal of Cancer, 1996
- Vascular endothelial growth factorEuropean Journal of Cancer, 1996
- Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomasAnnals of Oncology, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Suppression of VEGF‐induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin ABritish Journal of Pharmacology, 1995
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cellsJournal of Cellular Physiology, 1992
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983